Skip to main content
Top
Published in: BMC Dermatology 1/2011

Open Access 01-12-2011 | Database

Mapping randomized controlled trials of treatments for eczema - The GREAT database (The Global Resource of Eczema Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010)

Authors: Helen Nankervis, Alan Maplethorpe, Hywel C Williams

Published in: BMC Dermatology | Issue 1/2011

Login to get access

Abstract

Background

Massive duplication of effort occurs when researchers all over the world undertake extensive searches for randomized controlled trials when preparing systematic reviews, when developing evidence-based guidelines and when applying for research funding for eczema treatments. Such duplication wastes valuable resources.
Searching for randomized controlled trials of eczema is a laborious task involving scrutiny of thousands of individual references from diverse electronic databases in order to obtain a few papers of interest. Clinicians and patients who wish to find out more about a particular treatment are at risk of missing the relevant evidence if they are not trained in electronic bibliographic searching. Systematic reviews cannot be relied upon to comprehensively inform current optimal eczema treatments due to incomplete coverage and because many may be out of date.
An international, publically available and comprehensive resource which brings together all randomized controlled trials on eczema treatment using a highly sensitive search has the potential to release more filtered knowledge about patient care to those who need it most and to significantly shorten the duration and costs of many clinical eczema research and guideline projects.

Description

The G lobal R esource of E czemA T rials brings together information on all randomized controlled trials of eczema treatments published from the beginning of 2000 up to the end of 2010 and will be updated every month.
We searched the Cochrane Central Register of Controlled Trials in The Cochrane Library and the Cochrane Skin Group Specialised Register, MEDLINE, EMBASE, LILACS, AMED and CINHAL databases. We included 268 RCTs (24th March 2011) covering over 70 different treatment interventions.
The structure of the Global Resource of Eczema Trials allows the user as much, or as little, specificity when retrieving information on trials as they wish, in an easy to use format. For each trial, the database gives the citation for the published report and also provides enough information to enable a user to decide whether the trial is worth further scrutiny.

Conclusions

The Global Resource of Eczema Trials has been created to facilitate knowledge mobilization into healthcare and to reduce wastage of research time through unnecessary duplication. The collective time saved by research groups around the world can now be used to make strides in optimising the treatment of eczema, in order to further benefit people with eczema. The database can be accessed free of charge at http://​www.​greatdatabase.​org.​uk
Appendix
Available only for authorised users
Literature
1.
go back to reference Johansson SGO, O'B Hourihane J, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B: A revised nomenclature for allergy. Allergy 2001, 56: 813–24. 10.1034/j.1398-9995.2001.t01-1-00001.xCrossRefPubMed Johansson SGO, O'B Hourihane J, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B: A revised nomenclature for allergy. Allergy 2001, 56: 813–24. 10.1034/j.1398-9995.2001.t01-1-00001.xCrossRefPubMed
2.
go back to reference Odhiambo J, Williams H, Clayton T, Robertson C, Asher MI, the ISAAC Phase Three Study group: Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Journal of Allergy and Clinical Immunology 2009, 124: 1251–8. 10.1016/j.jaci.2009.10.009CrossRefPubMed Odhiambo J, Williams H, Clayton T, Robertson C, Asher MI, the ISAAC Phase Three Study group: Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Journal of Allergy and Clinical Immunology 2009, 124: 1251–8. 10.1016/j.jaci.2009.10.009CrossRefPubMed
3.
go back to reference Nankervis H, Smith EV, Boyle RJ, Rushton L, Williams HC, Hewson DM, Platts-Mills T: House dust mite reduction and avoidance measures for treating eczema (Protocol). Cochrane Database of Systematic Reviews 2010, (3):Art. No.: CD008426. Nankervis H, Smith EV, Boyle RJ, Rushton L, Williams HC, Hewson DM, Platts-Mills T: House dust mite reduction and avoidance measures for treating eczema (Protocol). Cochrane Database of Systematic Reviews 2010, (3):Art. No.: CD008426.
4.
go back to reference Williams H, Stewart A, von Mutius E, Cookson B, Anderson HR, the International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study groups: Is eczema really on the increase worldwide? Journal Allergy and Clinical Immunology 2008, 121: 947–54. 10.1016/j.jaci.2007.11.004CrossRef Williams H, Stewart A, von Mutius E, Cookson B, Anderson HR, the International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study groups: Is eczema really on the increase worldwide? Journal Allergy and Clinical Immunology 2008, 121: 947–54. 10.1016/j.jaci.2007.11.004CrossRef
5.
go back to reference Meltzer LJ, Moore M: Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. Journal of Pediatric Psychology 2008, 33(3):279–91.CrossRefPubMed Meltzer LJ, Moore M: Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. Journal of Pediatric Psychology 2008, 33(3):279–91.CrossRefPubMed
6.
go back to reference Mancini AJ, Kaulback K, Chamlin SL: The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatric Dermatology 2008, 25(1):1–6. 10.1111/j.1525-1470.2007.00572.xCrossRefPubMed Mancini AJ, Kaulback K, Chamlin SL: The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatric Dermatology 2008, 25(1):1–6. 10.1111/j.1525-1470.2007.00572.xCrossRefPubMed
8.
go back to reference Garritty C, Tsertsvadze A, Tricco AC, Sampson M, Moher D: Updating Systematic Reviews: An International Survey. PLoS ONE 2010, 5(4):e9914. 10.1371/journal.pone.0009914CrossRefPubMedPubMedCentral Garritty C, Tsertsvadze A, Tricco AC, Sampson M, Moher D: Updating Systematic Reviews: An International Survey. PLoS ONE 2010, 5(4):e9914. 10.1371/journal.pone.0009914CrossRefPubMedPubMedCentral
9.
go back to reference Betrán AP, Say L, Gülmezoglu AM, Allen T, Hampson L: Effectiveness of different databases in identifying studies for systematic reviews: experience from the WHO systematic review of maternal morbidity and mortality. BMC Medical Research Methodology 2005, 5: 6. 10.1186/1471-2288-5-6CrossRefPubMedPubMedCentral Betrán AP, Say L, Gülmezoglu AM, Allen T, Hampson L: Effectiveness of different databases in identifying studies for systematic reviews: experience from the WHO systematic review of maternal morbidity and mortality. BMC Medical Research Methodology 2005, 5: 6. 10.1186/1471-2288-5-6CrossRefPubMedPubMedCentral
10.
go back to reference Lefebvre C, Manheimer E, Glanville J: Chapter 6: Searching for studies.In Cochrane Handbook for Systematic Reviews of Interventions Edited by: Higgins JPT, Green S. The Cochrane Collaboration; 2009. Version 5.0.2 (updated September 2009) [http://www.cochrane-handbook.org] Lefebvre C, Manheimer E, Glanville J: Chapter 6: Searching for studies.In Cochrane Handbook for Systematic Reviews of Interventions Edited by: Higgins JPT, Green S. The Cochrane Collaboration; 2009. Version 5.0.2 (updated September 2009) [http://​www.​cochrane-handbook.​org]
12.
go back to reference Hoare C, Li Wan Po A, Williams H: Systematic review of treatments of atopic eczema. Health Technology Assessment 2000., 4(37): Hoare C, Li Wan Po A, Williams H: Systematic review of treatments of atopic eczema. Health Technology Assessment 2000., 4(37):
13.
go back to reference Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Dermato - Venereologia Supplementum 1980, 92: 44–7. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Dermato - Venereologia Supplementum 1980, 92: 44–7.
14.
go back to reference Williams HC, Burney PGJ, Hay RJ, Archer CB, Shipley MJ, Hunter JJA, Bingham AE, Finlay AY, Pembroke AC, Graham-Brown RAC, Atherton DA, Lewis-Jones MS, Holden CA, Harper JI, Champion RH, Poyner TF, Launer J, David TJ: The U.K Working Party's diagnostic criteria for atopic dermatitis. British Journal of Dermatology 1994, 131(3):383–96. 10.1111/j.1365-2133.1994.tb08530.xCrossRefPubMed Williams HC, Burney PGJ, Hay RJ, Archer CB, Shipley MJ, Hunter JJA, Bingham AE, Finlay AY, Pembroke AC, Graham-Brown RAC, Atherton DA, Lewis-Jones MS, Holden CA, Harper JI, Champion RH, Poyner TF, Launer J, David TJ: The U.K Working Party's diagnostic criteria for atopic dermatitis. British Journal of Dermatology 1994, 131(3):383–96. 10.1111/j.1365-2133.1994.tb08530.xCrossRefPubMed
Metadata
Title
Mapping randomized controlled trials of treatments for eczema - The GREAT database (The Global Resource of Eczema Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010)
Authors
Helen Nankervis
Alan Maplethorpe
Hywel C Williams
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Dermatology / Issue 1/2011
Electronic ISSN: 1471-5945
DOI
https://doi.org/10.1186/1471-5945-11-10

Other articles of this Issue 1/2011

BMC Dermatology 1/2011 Go to the issue